Advice
Development of this evidence summary
Development of this evidence summary
This evidence summary was developed for NICE by Bazian Ltd. The integrated process statement sets out the process NICE uses to select topics for the evidence summaries for unlicensed/off-label medicines and how the summaries are developed, quality assured and approved for publication.
Peer reviewers and contributors
Emma Chambers, Public Involvement Adviser, Public Involvement Programme, NICE
Steve Hill, General Manager, Ipsen Limited
Allergan Ltd